Alterations of the cyclin-dependent kinase inhibitor genes CDKN2A, CDKN2B and CDKN2C in atypical and anaplastic meningiomas

被引：0
|
作者：
Boström, J
Meyer-Puttlitz, B
Blaschke, B
Wolter, M
Weber, RG
Lichter, P
Collins, VP
Reifenberger, G
机构：
[1] Univ Bonn, Med Ctr, Dept Neurosurg, D-5300 Bonn, Germany
[2] Univ Bonn, Med Ctr, Dept Neuropathol, D-5300 Bonn, Germany
[3] Univ Heidelberg, Dept Human Genet, Heidelberg, Germany
[4] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
来源：
BRAIN PATHOLOGY | 2000年 / 10卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：742 / 742
页数：1
相关论文
共 50 条
  • [41] Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets
    Walker, GJ
    Flores, JF
    Glendening, JM
    Lin, AHT
    Markl, IDC
    Fountain, JW
    GENES CHROMOSOMES & CANCER, 1998, 22 (02): : 157 - 163
  • [42] De novo methylation of tumour suppressor genes CDKN2A and CDKN2B is a rare finding in B-cell chronic lymphocytic leukaemia
    Martel, V
    Guerci, A
    Humbert, JC
    Gregoire, MT
    Chery, M
    Lederlin, P
    Jonveaux, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) : 320 - 324
  • [43] Concomitant Deletions of IKZF1, CDKN2A, and CDKN2B in Pediatric B-Acute Lymphoblastic Leukemia
    Honebrink, Theodore
    Peterson, Jess
    Yohe, Sophia
    Thyagarajan, Bharat
    Peterson, Randolph
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (03) : 472 - 472
  • [44] Serial studies of methylation of CDKN2B and CDKN2A in relapsed acute promyelocytic leukaemia treated with arsenic trioxide
    Au, WY
    Fung, AT
    Ma, ES
    Chan, CH
    Wong, KF
    Chim, CS
    Liang, RH
    Kwong, YL
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (05) : 632 - 635
  • [45] Association of CDKN2A/CDKN2B Gene Polymorphisms with Increased Susceptibility to Intracranial Aneurysm in a Chinese Han Population
    Cui, Xiaopeng
    Xin, Wen-Qiang
    Wang, Bangyue
    Zhao, Yan
    Hou, Changkai
    Cai, Shifei
    Peng, Chao
    Wang, Zhen
    Li, Jian
    Huan, Linchun
    Chen, Lei
    Yang, Xinyu
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 1443 - 1449
  • [46] Pancreatic adenocarcinomas without KRAS, TP53, CDKN2A and SMAD4 mutations and CDKN2A/CDKN2B copy number alterations: a review of the genomic landscape to unveil therapeutic avenues
    Voutsadakis, Ioannis A.
    Digklia, Antonia
    CHINESE CLINICAL ONCOLOGY, 2023, 12 (01)
  • [47] COMBINED ALTERATIONS IN MAPK PATHWAY GENES, CDKN2A/B AND ATRX CHARACTERIZE ANAPLASTIC PILOCYTIC ASTROCYTOMA
    Kratz, Annekathrin
    Sahm, Felix
    Schrimpf, Daniel
    Jones, David T.
    Reuss, David
    Koelsche, Christian
    Huang, Kristin
    Wefers, Annika K.
    Hovestadt, Volker
    Gramatzki, Dorothee
    Felsberg, Joerg
    Koch, Arend
    Thomale, UlrichW.
    Reifenberger, Guido
    Becker, Albert
    Hans, Volkmar
    Prinz, Marco
    Staszewski, Ori
    Acker, Till
    Dohmen-Scheufler, Hildegard
    Hartmann, Christian
    Mueller, Wolf
    Tuffaha, Muin S. A.
    Paulus, Werner
    Hess, Katharina
    Brokinkel, Benjamin
    Schittenhelm, Jens
    Monoranu, Camelia
    Kessler, Almuth Friederike
    Buslei, Rolf
    Deckert, Martina
    Mawrin, Christian
    Kohlhof, Patricia
    Hewer, Ekkehard
    Olar, Adriana
    Rodriguez, Fausto
    Giannini, Caterina
    NageswaraRao, Amulya A.
    Weller, Michael
    Pohl, Ute
    Brandner, Sebastian
    Pfister, Stefan M.
    von Deimling, Andreas
    Capper, David
    NEURO-ONCOLOGY, 2016, 18 : 63 - 63
  • [48] COMBINED ALTERATIONS IN MAPK PATHWAY GENES, CDKN2A/B AND ATRX CHARACTERIZE ANAPLASTIC PILOCYTIC ASTROCYTOMA
    Kratz, A.
    Sahm, F.
    Schrimpf, D.
    Jones, D. T.
    Reuss, D. E.
    Schittenhelm, J.
    Gramatzki, D.
    Felsberg, J.
    von Deimling, A.
    Capper, D.
    NEURO-ONCOLOGY, 2016, 18 : 52 - 52
  • [49] Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism
    Shani Journo
    Anat Klein Goldberg
    Ethan S Sokol
    Lotem Zinger
    Metsada Pasmanik-Chor
    Boris Sarvin
    Dor Simkin
    Sivan Fuchs
    Tomer Shlomi
    Ido Wolf
    Tami Rubinek
    Oncogene, 2022, 41 : 1468 - 1481
  • [50] The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma
    Prins, JB
    Williamson, KA
    Kamp, MMK
    Van Hezik, EJ
    Van der Kwast, TH
    Hagemeijer, A
    Versnel, MA
    INTERNATIONAL JOURNAL OF CANCER, 1998, 75 (04) : 649 - 653
12345